vs
ICU MEDICAL INC（ICUI）与Childrens Place, Inc.（PLCE）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Childrens Place, Inc.的1.6倍（$540.7M vs $339.5M），Childrens Place, Inc.净利率更高（-1.3% vs -2.9%，领先1.6%），Childrens Place, Inc.同比增速更快（-13.0% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $-3.4M），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -13.6%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Children’s Place是专业儿童服饰零售商，产品主要以旗下自有品牌发售，涵盖Gymboree、Sugar & Jade、PJ Place、Crazy 8等。目前该品牌在美国、加拿大、波多黎各共开设约525家门店，同时通过两个线上渠道以及15个国家的5家加盟合作伙伴开展销售，产品涵盖上衣、裙装、鞋履、裤装、睡衣、背包等全品类儿童服饰配件。
ICUI vs PLCE — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $339.5M |
| 净利润 | $-15.7M | $-4.3M |
| 毛利率 | 37.5% | 33.1% |
| 营业利润率 | 1.0% | 1.1% |
| 净利率 | -2.9% | -1.3% |
| 营收同比 | -14.1% | -13.0% |
| 净利润同比 | 34.0% | -121.5% |
| 每股收益（稀释后） | $-0.63 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $540.7M | $339.5M | ||
| Q3 25 | $537.0M | $298.0M | ||
| Q2 25 | $548.9M | $242.1M | ||
| Q1 25 | $604.7M | $408.6M | ||
| Q4 24 | $629.8M | $390.2M | ||
| Q3 24 | $589.1M | $319.7M | ||
| Q2 24 | $596.5M | $267.9M | ||
| Q1 24 | $566.7M | $455.0M |
| Q4 25 | $-15.7M | $-4.3M | ||
| Q3 25 | $-3.4M | $-5.4M | ||
| Q2 25 | $35.3M | $-34.0M | ||
| Q1 25 | $-15.5M | $-8.0M | ||
| Q4 24 | $-23.8M | $20.1M | ||
| Q3 24 | $-33.0M | $-32.1M | ||
| Q2 24 | $-21.4M | $-37.8M | ||
| Q1 24 | $-39.5M | $-128.8M |
| Q4 25 | 37.5% | 33.1% | ||
| Q3 25 | 37.4% | 34.0% | ||
| Q2 25 | 37.9% | 29.2% | ||
| Q1 25 | 34.7% | 28.5% | ||
| Q4 24 | 36.1% | 35.5% | ||
| Q3 24 | 34.8% | 35.0% | ||
| Q2 24 | 34.8% | 34.6% | ||
| Q1 24 | 32.7% | 21.8% |
| Q4 25 | 1.0% | 1.1% | ||
| Q3 25 | 2.6% | 1.4% | ||
| Q2 25 | 1.9% | -10.0% | ||
| Q1 25 | 2.1% | 1.7% | ||
| Q4 24 | 6.0% | 7.5% | ||
| Q3 24 | 1.4% | -6.8% | ||
| Q2 24 | 1.3% | -10.4% | ||
| Q1 24 | -1.9% | -13.6% |
| Q4 25 | -2.9% | -1.3% | ||
| Q3 25 | -0.6% | -1.8% | ||
| Q2 25 | 6.4% | -14.1% | ||
| Q1 25 | -2.6% | -2.0% | ||
| Q4 24 | -3.8% | 5.1% | ||
| Q3 24 | -5.6% | -10.0% | ||
| Q2 24 | -3.6% | -14.1% | ||
| Q1 24 | -7.0% | -28.3% |
| Q4 25 | $-0.63 | $-0.19 | ||
| Q3 25 | $-0.14 | $-0.24 | ||
| Q2 25 | $1.43 | $-1.57 | ||
| Q1 25 | $-0.63 | $-0.60 | ||
| Q4 24 | $-0.97 | $1.57 | ||
| Q3 24 | $-1.35 | $-2.51 | ||
| Q2 24 | $-0.88 | $-2.98 | ||
| Q1 24 | $-1.63 | $-10.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $7.3M |
| 总债务越低越好 | — | $107.4M |
| 股东权益账面价值 | $2.1B | $-8.6M |
| 总资产 | $4.1B | $762.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $7.3M | ||
| Q3 25 | — | $7.8M | ||
| Q2 25 | — | $5.7M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | $308.6M | $5.7M | ||
| Q3 24 | $312.5M | $9.6M | ||
| Q2 24 | $302.6M | $13.0M | ||
| Q1 24 | $251.4M | $13.6M |
| Q4 25 | — | $107.4M | ||
| Q3 25 | — | $107.2M | ||
| Q2 25 | — | $107.0M | ||
| Q1 25 | — | $166.0M | ||
| Q4 24 | — | $165.7M | ||
| Q3 24 | — | $165.4M | ||
| Q2 24 | — | $166.6M | ||
| Q1 24 | — | $49.8M |
| Q4 25 | $2.1B | $-8.6M | ||
| Q3 25 | $2.1B | $-4.9M | ||
| Q2 25 | $2.1B | $1.4M | ||
| Q1 25 | $2.0B | $-59.4M | ||
| Q4 24 | $2.0B | $-49.6M | ||
| Q3 24 | $2.0B | $-68.9M | ||
| Q2 24 | $2.0B | $-34.9M | ||
| Q1 24 | $2.1B | $-9.0M |
| Q4 25 | $4.1B | $762.5M | ||
| Q3 25 | $4.1B | $805.1M | ||
| Q2 25 | $4.1B | $779.6M | ||
| Q1 25 | $4.2B | $747.6M | ||
| Q4 24 | $4.2B | $888.8M | ||
| Q3 24 | $4.3B | $921.4M | ||
| Q2 24 | $4.3B | $848.3M | ||
| Q1 24 | $4.3B | $800.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 75.63× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $6.2M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $-3.4M |
| 自由现金流率自由现金流/营收 | 6.6% | -1.0% |
| 资本支出强度资本支出/营收 | 4.6% | 2.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | $39.5M |
8季度趋势，按日历期对齐
| Q4 25 | $60.6M | $6.2M | ||
| Q3 25 | $56.7M | $-30.5M | ||
| Q2 25 | $11.2M | $-43.0M | ||
| Q1 25 | $51.3M | $121.3M | ||
| Q4 24 | $40.2M | $-44.2M | ||
| Q3 24 | $36.1M | $-83.9M | ||
| Q2 24 | $82.0M | $-110.8M | ||
| Q1 24 | $45.8M | $135.4M |
| Q4 25 | $36.0M | $-3.4M | ||
| Q3 25 | $27.6M | $-31.9M | ||
| Q2 25 | $-8.5M | $-46.4M | ||
| Q1 25 | $36.7M | $121.2M | ||
| Q4 24 | $16.1M | $-47.7M | ||
| Q3 24 | $16.2M | $-91.7M | ||
| Q2 24 | $62.5M | $-115.5M | ||
| Q1 24 | $29.9M | $132.2M |
| Q4 25 | 6.6% | -1.0% | ||
| Q3 25 | 5.1% | -10.7% | ||
| Q2 25 | -1.5% | -19.2% | ||
| Q1 25 | 6.1% | 29.7% | ||
| Q4 24 | 2.6% | -12.2% | ||
| Q3 24 | 2.7% | -28.7% | ||
| Q2 24 | 10.5% | -43.1% | ||
| Q1 24 | 5.3% | 29.1% |
| Q4 25 | 4.6% | 2.8% | ||
| Q3 25 | 5.4% | 0.5% | ||
| Q2 25 | 3.6% | 1.4% | ||
| Q1 25 | 2.4% | 0.0% | ||
| Q4 24 | 3.8% | 0.9% | ||
| Q3 24 | 3.4% | 2.4% | ||
| Q2 24 | 3.3% | 1.8% | ||
| Q1 24 | 2.8% | 0.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
PLCE
| The Childrens Place US | $307.4M | 91% |
| The Childrens Place International | $32.1M | 9% |
| Gift Cards | $1.7M | 1% |
